The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Busted flush with no confidence in the BOD................AIM IS A JOKE....!
There is nothing left other than a deluded, propped up CEO........and a tiny revenue. It compares nicely to Cineworld who have dropped from c.54p to 2p...........and they really are a busted flush. 2.6p for ODX who'd have thought............least of all the CFO.........! Perhaps a real CEO would run a set of diagnostics over Omeag and conclude DNR......1
This will fail - yes FAIL NOT FALL when the interims announced. No revenue worth mentioning and a BOD who extract all the last remaining cash in wages - and not one of them has a proven track record of sales growth in the Diagnostics Sector.......Dead in a ditch now........Chug Chug......Pop...!
Yep - that is my sell. I am slowly unwinding the position at a substantial loss. The delayed Prelims are just the last nail in the coffin for me. Woeful BOD and share price destruction - see my 53p to 3p in 12 months post of yesterday.........The BOD need to be sacked and the main Protagonist - Mr Lea is Lining this up for a H&N sale. AIM is a wage of people’s time and money.....go to the 250 and buy there. I think Mr Lea will jump as even he knows the 12p LTIP is unattainable.........The only saving is Mr. Lea will struggle to get the next CFO gig with this shocker on his CV, he will claim he saved it from going bust, but in reality - at 3p it pretty much is and warrants in play too..........Retirement looms for Mr. Lea now......Chug Chug
Nothing can repair the share price damage achieved in the 12 months Chris Lea has presided over the CFO role. For many older and much more recent share holders have been wiped out, short of the company going bust. On the flip side both new leaders have retained their salaries and probably increased their remuneration in the 12 months in relation to Jag’s new CEO role. All the family silver now sold off and a tiny revenue stream left. Another AIM disaster.......TAX losses now guys is the only remaining value having sold the shares.
Yep - Tradesin correct, this is not even viable as a punt now.....Chug Chug....basically the market is saying Jag will not deliver value in the last remaining business unit........as a result the market observers are washing their hands with it.
This is uninvestabke now.......
1. Warrants at 4p
2. No clarity on CD4 sale value
3. No figure on the payment received from Abingdon
4. Turnover at only £9m going forward
5. PLC costs vs. turnover unsustainable
6. Unresolved DHSC claim
7. Jag has no track record of success - but is CEO
8. Any shareholder in above 8p is wiped out.
9. H&N next to sold off at knock down price
At 3.3p today the market is calling the company and its BOD out on this shambles.
Just another AIM train wreck......and I am selling out of this dog with fleas. Last post on the subject. Chug Chug........
£4m......as that is approx half of the cash invest in it so far.........£4m is worth a bit in terms of growing H&N. That would also pass the ‘fair value’ test......which tends to dictate a c.40% to 50% exit value.....not great a result I know, but aligns to the return to the core profit making of H&N.
This is way too low for the market cap, given CD4 exit - cash payment of today and a growing H&N business unit........All the heavy lifting complete in a few weeks.......Choooo Chooooo
Fun and games as usual on a Monday from ODX........
Fairly obvious the motions which are playing out at ODX are taken straight from the Private Equity playbook. Get rid of the rubbish and chop overhead, focus on large markets - US. Establish enough funding in place to substantially grow the most profitable element - H&N. If this isn’t the operating model of PE, then wait for the offer for the showroom ready Omega Diagnostics 2023.......This will jump or be snapped up by hungry PE operators in this sector........Target 8p...short term.
Can I ask that Captain starts to look over the bow at what is coming up rather than over the stern to see what rocks we just missed, which would have scuppered the good ship ‘ODX’ had it not been for a very competent 1st Officer by the name of the Lea. Your are dwelling on the past - grow a pair and move on honestly.....it’s becoming very painful. Period.
Now the sellers are done giving their shares away the buying is starting.......In on the bottom rung at this price........Choooo Choooo
No bad news in that RNS...........Too cheap at 3.4p for a growth story going forward. Have you noticed that since Mr. Lea has joined the heavy lifting has been nearly completed in under a year. He has cleaned this mess up to point of being an opportunity now. I suggest that the recovery is well underway on this and is poised for a jump to at least £12m market cap....choooo chooooo
A funded pure H&N business for only £7m.......which is growing fast. Get real - this has proper potential now.......Choo Choo.
Easily worth 3 x current market cap = £20m.....
A good bit of progress made in offloading CD4.....OD looking attainable and a royalty.......nothing bad in that RNS......Chooooo Choooooo
Buying at 3.18p is an absolute bargain especially on the expectation of an update by RNS......
Concerted effort to lower the price.......this is a pre RNS manoeuvre by third parties to really profit....Chooo Choooo
Your posts are not accurate......the current CFO is very experienced and knows the disclosure rules and price sensitivIty test inside out. Can you abstain from posting further today and just let the adults get on with it. Also referring to the BOD as the clown show is just not helpful at this point in the recovery........Go for a walk in the fresh air and calm down you will feel better......honestly......Choooo. choooooo.